Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Auto rebalancing and capital gains management covers how automated tweaks can curb tax impact while preserving strategy.
28,655 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
A Murphy USA senior executive recently sold shares in an open-market move valued at roughly $344,000. This article br...
Bitcoin has pulled back sharply from recent highs, leaving both new and seasoned investors wondering what comes next....
When a mid-sized advisory firm increases its stake in an international equity ETF, it can reveal a fresh take on glob...
The stock market has shown impressive strength, but political forces and monetary policy tensions can tilt the landsc...
A closer look at stealthgas (gass) 2026 earnings reveals how fleet utilization, charter rates, and debt shape this ga...
A renewed wave of active investors is reshaping the discount broker scene. Charles Schwab stands out, quietly convert...
As March closes, a simple, disciplined core holding stands out for many investors: the Vanguard S&P 500 ETF (VOO). Th...
A director at AMN Healthcare recently disclosed selling about 3,681 shares for roughly $114,000 as the stock jumped 4...
At New Delhi's AI Impact Summit, a staged gesture exposed rivalries among top AI leaders, triggering a rethink of AI ...
AI is reshaping business models across industries. Here are three AI stocks you can buy and hold for the long term, w...
Bitcoin is showing notable strength with a 3.7% rise in a single session. This piece breaks down the catalysts behind...